Lingbing Li
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery 24
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems 11
- Molecular Medicine top 5%
- Hydrogels: synthesis, properties, applications 3
- Polymers and Plastics top 10%
- Dendrimers and Hyperbranched Polymers 6
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics 8
-
- Drug Transport and Resistance Mechanisms 8
-
- RNA Interference and Gene Delivery 6
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
Lingbing Li
34 papers receiving 850 citations
Peers
Comparison fields: 5 of 88
- Biomaterials 456
- Pharmaceutical Science 196
- Molecular Medicine 79
- Polymers and Plastics 102
- Biomedical Engineering 258
Countries citing papers authored by Lingbing Li
This map shows the geographic impact of Lingbing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingbing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingbing Li more than expected).
Fields of papers citing papers by Lingbing Li
This network shows the impact of papers produced by Lingbing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingbing Li. The network helps show where Lingbing Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lingbing Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 7 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 3 | |
| 6 | 2021 | 16 | |
| 7 | 2020 | 45 | |
| 8 | 2018 | 8 | |
| 9 | 2018 | 35 | |
| 10 | 2016 | 47 | |
| 11 | 2016 | 37 | |
| 12 | 2016 | 46 | |
| 13 | 2015 | 18 | |
| 14 | 2014 | 13 | |
| 15 | 2011 | 8 | |
| 16 | 2010 | 52 | |
| 17 | Mixed micelles made of Pluronic P105 and L61 as pharmaceutical nanocarriers for camptothecin | 2009 | 1 |
| 18 | Studies on Preparation of Quercetin Solid Lipid Nanoparticles and Oral Absorption in Mice | 2008 | 1 |
| 19 | 2008 | 27 | |
| 20 | 2007 | 60 |
About Lingbing Li
Lingbing Li is a scholar working on Biomaterials, Pharmaceutical Science and Molecular Medicine, having authored 34 papers that have together received 867 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (24 papers), Advanced Drug Delivery Systems (11 papers), Drug Transport and Resistance Mechanisms (8 papers), Nanoplatforms for cancer theranostics (8 papers), Dendrimers and Hyperbranched Polymers (6 papers), RNA Interference and Gene Delivery (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Hydrogels: synthesis, properties, applications (3 papers). The work is most often cited by research in Biomaterials (456 citations), Pharmaceutical Science (196 citations) and Molecular Medicine (79 citations). Lingbing Li has collaborated with scholars based in China and Hong Kong. Frequent co-authors include Yakun Ma, Xiaohui Fan, Guangxi Zhai, Wei Xu, Yanli Zhao, Jianbo Ji, Xuling Chen, Na Li, Yixin Zhu and Chunfen Yang. Their work appears in journals such as Colloids and Surfaces B Biointerfaces, Materials Science and Engineering C, Journal of drug targeting, Journal of Colloid and Interface Science and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.